Christopher Peetz - 02 Feb 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
02 Feb 2024
Net transactions value
-$157,491
Form type
4
Filing time
05 Feb 2024, 21:04:12 UTC
Previous filing
25 Jan 2024
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale $157,491 -6,013 -5.5% $26.19 104,112 02 Feb 2024 Direct F1
holding MIRM Common Stock 201,570 02 Feb 2024 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.